- Home
- OIO vs PLX Comparison
OIO vs PLX Comparison
Compare OIO & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.00
Company Overview
Basic Information| Metric | OIO | PLX |
|---|---|---|
| Founded | 1999 | 1993 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.7M | 159.5M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | OIO | PLX |
|---|---|---|
| Price | $2.11 | $2.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 27.9K | ★ 771.4K |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $52,744,000.00 |
| Revenue This Year | N/A | $36.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.50 | $1.34 |
| 52 Week High | $7.50 | $3.19 |
Technical Indicators
Market Signals| Indicator | OIO | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 45.35 |
| Support Level | $1.60 | $1.87 |
| Resistance Level | $7.50 | $2.17 |
| Average True Range (ATR) | 0.21 | 0.07 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 61.28 | 35.09 |
Price Performance
Historical Comparison OIO
PLX
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.